Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | +32.08% |
|
+43.21% | -80.56% |
Jul. 09 | AEON Biopharma Plans to Pursue Biosimilar Regulatory Pathway for ABP-450 | MT |
Jul. 09 | AEON Biopharma, Inc. Announces Strategic Reprioritization to Pursue A Biosimilar Pathway for ABP-450 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
41.47M | - | - | - | - | - | |
127B | ||||||
117B | ||||||
27.77B | - | |||||
20.44B | - | |||||
16.62B |